MARATTO

article · African Journal of Laboratory Medicine

Additional sex combs-like 1 variants in an acute myeloid leukaemia and a general elderly cohort in central South Africa

Abstract

Background: ) gene confer poor prognosis and are frequently involved in clonal haematopoiesis of indeterminate potential, with increasing prevalence with advancing age. Objective: variants in an AML cohort and general elderly population in central South Africa. Methods: exon 12 were performed on all samples between 01 October 2023 and 30 September 2024. Results: variants were detected in 68 of the 100 elderly participants aged 65-88 years (mean 71 years). Variants in the coding regions included synonymous (58.4%) and missense (41.6%) variants. Benign variants were detected in 29% of the elderly participants, while variants of uncertain significance were present in 2%, each with a variant allele frequency of ≥ 20%. No pathogenic or likely pathogenic variants were identified. Conclusion: exon 12 variants in our AML cohort was consistent with international data. Variants in the elderly population were very prevalent; however, with no actionable variants capable of driving clonal expansion, clonal haematopoiesis of indeterminate potential was not detected. The variants of uncertain significance at allele frequencies of ≥ 2% likely suggest a clonal haematopoietic process. What this study adds: testing in all AML patients is not recommended in our resource-limited setting. Testing should be individualised according to its potential clinical impact, using high-throughput sequencing with clinically relevant variant classification.

Research topics

  • Acute Myeloid Leukemia Research
  • Blood disorders and treatments
  • Genomics and Rare Diseases

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4102/ajlm.v15i1.3061

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.